Antagonism of α1-adrenoceptor agonist-induced responses by rilmenidine in vascular smooth muscle

European Journal of Pharmacology

Volumn 341, Issue 2-3, 1998, Pages 179-185

  Cario Toumaniantz, Chrystelle ^a   Loirand, Gervaise ^a   Pacaud, Pierre ^a  

^a INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

Author keywords

Adrenoceptor; Ca2+; Contraction; Intracellular; Portal vein

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR STIMULATING AGENT; ALPHA 2 ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CALCIUM ION; NORADRENALIN; PHENYLEPHRINE; PRAZOSIN; RILMENIDINE; YOHIMBINE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; OXAZOLE DERIVATIVE;

ALPHA ADRENERGIC STIMULATION; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG MECHANISM; HYPERTENSION; NONHUMAN; PORTAL VEIN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; VASCULAR SMOOTH MUSCLE; VASODILATATION; ANIMAL; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; MUSCLE CONTRACTION; WISTAR RAT;

ADRENERGIC ALPHA-AGONISTS; ANIMALS; CALCIUM; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; NOREPINEPHRINE; OXAZOLES; PHENYLEPHRINE; PORTAL VEIN; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC, ALPHA-1;

EID: 0032509560     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(97)01490-8     Document Type: Article

References (19)

1. 1-imidazoline receptors. J. Cardiovasc. Pharmacol. 20 (suppl. 4):1992;S1-S10.
2. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
3. Horiuti K. Mechanism of contracture on cooling of caffeine-treated frog skeletal muscle fibres. J. Physiol. (Lond.). 398:1988;131-148.
4. Koenig-Bérard E., Tierney C., Beau B., Delbarre G., Lhoste F., Labrid C. Cardiovascular and central nervous system effects of rilmenidine in rats. Am. J. Cardiol. 61:1988;22D-31D.
5. Kong J-.Q., Taylor D.A., Fleming W.W. Antagonism of norepinephrine by clonidine in the isolated rat mesenteric vascular bed. J. Pharmacol. Exp. Ther. 259:1991;653-658.
6. 2-oxazoline (S 3341), an alpha2-adrenoceptor agonist. J. Pharmacol. 16:1985;259-278.
7. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: An endogenous clonidine-displacing subtance in the brain. Science. 263:1994;966-969.
8. Marsault R., Taddei S., Boulanger C.M., Illiano S., Vanhoutte P.M. Rilmenidine activates postjunctional alpha1- and alpha2-adrenoceptors in canine saphenous vein. Fundam. Clin. Pharmacol. 10:1996;379-385.
9. McGrath J.C., Brown C.M., Daly C.J., Kendall D., MacKinnon A., Miller D.J., Nagadeh M., O'Dowd A., O'Dowd J.J., Pinthong D., Singh G., Templeton A.G.B., Wilson V.G. The relationship between the adrenoceptor and nonadrenoceptor-mediated effects of imidazoline- and imidazole-containing compounds. Ann. NY Acad. Sci. 763:1995;591-605.
10. - channels in response to noradrenaline in vascular myocytes. Br. J. Pharmacol. 104:1991;1000-1006.
11. 2+ store in portal vein smooth muscle cells. J. Biol. Chem. 268:1993;3866-3872.
12. Pfaffendorf M., Van Zwieten P.A. Mediation by the same muscarinic receptor subtype of phasic and tonic contractiles activities in the rat isolated portal vein. Br. J. Pharmacol. 108:1993;132-138.
13. Regunathan S., Reis D.J. Imidazoline receptors and their endogenous ligands. Annu. Rev. Pharmacol. Toxicol. 36:1996;511-544.
14. Sannajust F., Head G.A. Rilmenidine-induced hypotension in conscious rabbits involves imidazoline-preferring receptors. J. Cardiovasc. Pharmacol. 23:1994;42-50.
15. Silva E.G., Feres T., Vianna L.M., Okuyama P., Paiva T.B. Dual effect of clonidine on mesenteric artery adrenoceptors: Agonistic (alpha-2) and antagonistic (alpha-1). J. Pharmacol. Exp. Ther. 277:1996;872-876.
16. 1-agonist-induced vasoconstriction. Eur. J. Pharmacol. 230:1993;131-137.
17. Szabo B., Urban R. Mechanism of sympathoinhibition by imidazolines. In the imidazoline receptor. Ann. NY Acad. Sci. 763:1995;552-565.
18. 2-adrenoceptor agonist rilmenidine. Am. J. Cardiol. 61:1988;6D-14D.
19. Van Zwieten P.A. From alpha and beta to I1: An overview of sympathetic receptors involved in blood pressure control targets for drug treatment. J. Cardiovasc. Pharmacol. 27 (Suppl. 3):1996;S5-S10.